Clinical Trial Update: PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia [NA]

View source ↗

Summary

Clinical trial PROMISE III evaluating Percutaneous Deep Vein Arterialization for late-stage chronic limb-threatening ischemia; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Limb-threatening Ischemia
• Peripheral Arterial Disease

Snippet

Sponsor: LimFlow, Inc. | Conditions: Critical Limb Ischemia, Chronic Limb-Threatening Ischemia | NA | Status: RECRUITING